Lucid Diagnostics Inc. Stock-Based Compensation
Lucid Diagnostics Inc. (LUCD) reported Stock-Based Compensation of $3.23 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2025-11-12
- Lucid Diagnostics Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $1.14M, a 4.14% decline year-over-year.
- Lucid Diagnostics Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-06-30 was $1.14M, a 3.25% increase year-over-year.
- Lucid Diagnostics Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-03-31 was $949.00K, a 27.73% increase year-over-year.
- Lucid Diagnostics Inc. share-based payment arrangement, noncash expense for the quarter ending 2024-12-31 was $1.15M, a 53.61% increase year-over-year.
- Lucid Diagnostics Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $4.18M, a 27.40% decline from fiscal 2023.
- Lucid Diagnostics Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $5.76M, a 58.42% decline from fiscal 2022.
- Lucid Diagnostics Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $13.86M, a 51.73% increase from fiscal 2021.
- Lucid Diagnostics Inc. share-based payment arrangement, noncash expense for fiscal 2021 was $9.13M, a 13952.31% increase from fiscal 2020.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | $1.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $2.28M derived: sum of 2 quarters · filed 2025-11-12 | $3.23M 10-Q · filed 2025-11-12 | $4.38M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2025-06-30 | $1.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $2.09M 10-Q · filed 2025-08-12 | $3.24M derived: sum of 3 quarters · filed 2025-08-12 | $4.42M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2025-03-31 | $949.00K 10-Q · filed 2025-05-13 | $2.10M derived: sum of 2 quarters · filed 2025-05-13 | $3.28M derived: sum of 3 quarters · filed 2025-11-12 | $4.39M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-12-31 | $1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $2.33M derived: sum of 2 quarters · filed 2025-11-12 | $3.44M derived: sum of 3 quarters · filed 2025-11-12 | $4.18M 10-K · filed 2025-03-24 | ||||
| 2024-09-30 | $1.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $2.29M derived: sum of 2 quarters · filed 2025-11-12 | $3.03M 10-Q · filed 2025-11-12 | $3.78M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | $1.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $1.85M 10-Q · filed 2025-08-12 | $2.60M derived: sum of 3 quarters · filed 2025-08-12 | $3.63M derived: sum of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | $743.00K 10-Q · filed 2025-05-13 | $1.49M derived: sum of 2 quarters · filed 2025-05-13 | $2.52M derived: sum of 3 quarters · filed 2025-05-13 | $3.69M derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | $748.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $1.78M derived: sum of 2 quarters · filed 2025-03-24 | $2.94M derived: sum of 3 quarters · filed 2025-03-24 | $5.76M 10-K · filed 2025-03-24 | ||||
| 2023-09-30 | $1.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $2.20M derived: sum of 2 quarters · filed 2024-11-12 | $5.01M 10-Q · filed 2024-11-12 | $8.50M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | $1.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $3.98M 10-Q · filed 2024-08-12 | $7.47M derived: sum of 3 quarters · filed 2024-08-12 | $10.75M derived: sum of 4 quarters · filed 2024-08-12 | ||||
| 2023-03-31 | $2.82M 10-Q · filed 2024-05-13 | $6.30M derived: sum of 2 quarters · filed 2024-05-13 | $9.59M derived: sum of 3 quarters · filed 2024-05-13 | $13.43M derived: sum of 4 quarters · filed 2024-05-13 | ||||
| 2022-12-31 | $3.49M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $6.77M derived: sum of 2 quarters · filed 2024-03-25 | $10.61M derived: sum of 3 quarters · filed 2024-03-25 | $13.86M 10-K · filed 2024-03-25 | ||||
| 2022-09-30 | $3.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $7.12M derived: sum of 2 quarters · filed 2023-11-13 | $10.37M 10-Q · filed 2023-11-13 | $13.75M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | $3.84M 10-Q · filed 2022-08-15 | $7.09M 10-Q · filed 2023-08-14 | $7.68M 10-Q · filed 2022-08-15 | $10.47M derived: sum of 3 quarters · filed 2023-05-15 | $13.24M derived: sum of 4 quarters · filed 2023-05-15 | |||
| 2022-03-31 | $3.54M 10-Q · filed 2023-05-15 | $3.83M 10-Q · filed 2022-05-16 | $6.63M derived: sum of 2 quarters · filed 2023-05-15 | $9.40M derived: sum of 3 quarters · filed 2023-05-15 | $11.98M derived: sum of 4 quarters · filed 2023-05-15 | |||
| 2021-12-31 | $3.09M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $5.86M derived: sum of 2 quarters · filed 2023-03-14 | $8.44M derived: sum of 3 quarters · filed 2023-03-14 | $9.13M 10-K · filed 2023-03-14 | $9.60M 10-K · filed 2022-04-06 | |||
| 2021-09-30 | $2.77M 10-Q · filed 2021-11-23 | $5.35M derived: sum of 2 quarters · filed 2022-08-15 | $6.04M 10-Q · filed 2022-11-14 | $6.16M 10-Q · filed 2021-11-23 | $6.17M derived: sum of 4 quarters · filed 2022-08-15 | |||
| 2021-06-30 | $2.58M 10-Q · filed 2022-08-15 | $3.38M 10-Q · filed 2022-08-15 | $3.40M derived: sum of 3 quarters · filed 2022-08-15 | $3.42M derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | $805.00K 10-Q · filed 2022-05-16 | $820.91K derived: sum of 2 quarters · filed 2022-05-16 | $837.27K derived: sum of 3 quarters · filed 2022-05-16 | |||||
| 2020-12-31 | $15.91K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-06 | $32.27K derived: sum of 2 quarters · filed 2022-04-06 | $65.00K 10-K · filed 2022-04-06 | |||||
| 2020-09-30 | $16.36K 10-Q · filed 2021-11-23 | $49.09K 10-Q · filed 2021-11-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |